Skip to main content

Advertisement

Table 3 Logistic regression analysis of risk factors for metastatic sites

From: miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer

Variables Lung Brain Liver Bone Othersa
OR 95% CI P value OR 95% CI P value OR 95% CI P value OR 95% CI P value OR 95% CI P value
Age
Menopause
T3/4 1.1 0.7–1.5 0.748 1.4 0.8–2.2 0.167 1.5 0.9–2.3 0.080 0.9 0.6–1.2 0.435 1.7 1.0–3.0 0.049
N1/2/3 1.5 1.0–2.2 0.046 0.8 0.5–1.3 0.348 1.9 1.1–3.1 0.014 1.2 0.8–1.8 0.330 1.3 0.7–2.3 0.405
TNM II/III 1.7 0.8–3.4 0.143 2.0 0.8–5.2 0.138 1.0 0.4–2.6 0.994 3.0 1.4–6.5 0.005 1.4 0.4–4.7 .597
Surgery
Chemotherapy
Grade II/III 1.3 0.9–1.9 0.105 1.7 1.0–2.8 0.039 1.6 1.1–2.3 0.026 1.9 1.0–3.9 0.044
Ki-67
LVI (positive) 0.9 0.5–1.7 0.863 4.1 1.9–8.4 <0.001 1.1 0.5–2.4 0.760 1.3 0.7–2.4 0.371
miR-629-3p (high) 4.1 2.5–6.6 <0.001 1.6 0.8–3.1 0.147
  1. LVI Lymphovascular invasion
  2. A blank (–) field indicates that the variable was not significant in the univariate analysis and was not included in the multivariate analysis
  3. a“Others” refers to distant nodal, pleural/peritoneal, abdominal/mediastinal viscera, spinal cord, eye, and other unclassified organs